These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1602389)

  • 1. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.
    Cushing DJ; Zgombick JM; Nelson DL; Cohen ML
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1560-6. PubMed ID: 8667223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-induced relaxation in canine coronary artery smooth muscle.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1992 Oct; 263(1):123-9. PubMed ID: 1403777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of serotonin receptors in isolated rat intramyocardial coronary artery.
    Lai FM; Tanikella T; Cervoni P
    J Pharmacol Exp Ther; 1991 Jan; 256(1):164-8. PubMed ID: 1988655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
    Watts SW; Thompson JM
    J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle.
    Janssen P; Prins NH; Meulemans AL; Lefebvre RA
    Br J Pharmacol; 2002 May; 136(2):321-9. PubMed ID: 12010782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
    Cohen ML; Colbert WE
    J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
    Prins NH; Briejer MR; Schuurkes JA
    Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression.
    Verheggen R; Hundeshagen AG; Brown AM; Schindler M; Kaumann AJ
    Br J Pharmacol; 1998 Aug; 124(7):1345-54. PubMed ID: 9723944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
    Verheggen R; Freudenthaler S; Meyer-Dulheuer F; Kaumann AJ
    Br J Pharmacol; 1996 Jan; 117(2):283-92. PubMed ID: 8789380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
    Cohen ML; Robertson DW; Bloomquist WE; Wilson HC
    J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
    Cohen ML; Fuller RW; Kurz KD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for two populations of 5-hydroxytryptamine receptors in dog basilar artery.
    Frenken M
    J Pharmacol Exp Ther; 1989 Jul; 250(1):379-87. PubMed ID: 2545865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring clavines: antagonism/partial agonism at 5-HT2A receptors and antagonism at alpha 1-adrenoceptors in blood vessels.
    Pertz H
    Planta Med; 1996 Oct; 62(5):387-92. PubMed ID: 8923801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.